// App-Quantinova.ai

EP504 : DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN PATIENTS OLDER THAN 65 YEARS: ANALYSIS OF 3 YEAR REAL WORLD DATA OF PRACTICE PATTERNS AND OUTCOMES IN ENGLAND

Researchers

Presenter

  • Luke Hounsome

Principal Investigators

  • Toby Eyre

  • Robin Ireland

  • Andrew Hodson

  • Renata Walewska

  • Kirit Ardeshna

  • Sridhar Chaganti

  • Pam McKay

  • Andrew Davies

  • Christopher Fox

  • Nagesh Kalakonda

  • Paul Fields

Medical Centers

  • Rheumatology, UCL, London, United Kingdom

  • Rheumatology, Ipswich Hospitals NHS Trust, Ipswich, United Kingdom

  • Haematology, Universtiy of Birmingham, Birmingham, United Kingdom,

  • Rheumatology, Oxford University Hospitals NHS Foundation Trust, OXFORD, United Kingdom

  • Cancer Care, University Hospitals Dorset,Bournemouth,United Kingdom

  • Haematology, Guys and St Thomas Hospital, London, United Kingdom

  • Public Health England, London, United Kingdom

  • Haematology,Kings College London Hospitals,London,United Kingdom

  • Medical Oncology,Southampton General Hospital,Southampton,United Kingdom

  • Depts of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom

  • Haematology,Beatson Cancer Centre,Glasgow,United Kingdom

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A